Biocom California

JUST RELEASED: Our 2024 Economic Impact Report in partnership with Deloitte reveals that the life science sector in California directly provides more than 465K jobs and generates $414.2B in economic output. Access the full report here: https://bit.ly/44SrM7S

We are thrilled to announce the winners of our ninth annual Life Science Catalyst Awards. The awards celebrate rising and accomplished academics, entrepreneurs, investors, corporate leaders and business advisers who are making significant contributions to the life science industry in California before reaching their 40th birthday. Biocom California selected the 10 winners from an impressive pool of nominees from all facets of the life science industry, including pharma, diagnostics, venture funding, industrial biotech and digital health. In alphabetical order, the Life Science Catalyst Award winners are: •Denise Bronner, Ph.D., founder and CEO, Empactful Ventures, LLC •Tyler Brown, Ph.D., founder, chair and president, OUTbio San Diego •Nick Goeden, Ph.D., co-founder and chief technology officer, Capsida Biotherapeutics •Michael Henderson, M.D., CEO, Apogee Therapeutics •Sophia Lugo, co-founder, chairman and CEO, Radar Therapeutics •Ana Moreno, Ph.D., founder and CEO, Navega Therapeutics •Nindhana Paranthaman, M.D., executive medical director of clinical development, Summit Therapeutics, Inc. •Kevin Parker, Ph.D., CEO and co-founder, Cartography Biosciences •Hunter Reed, vice president, Alexandria Venture Investments at Alexandria Real Estate Equities, Inc. •David Weinberg, Ph.D., co-founder and CEO, ParcelBio The award winners will be highlighted in the Biocom California LifeLines digital platform and newsletter, on social media platforms and celebrated at our Annual Gala on November 21, 2024. Join us in congratulating this year’s award winners! See the winners here: https://bit.ly/3BLIGbt

In this month’s San Diego Newsletter, Aspen Neuroscience, Inc. announces expansion of autologous cell therapy manufacturing, Daré Bioscience, Inc. receives $10 million award from Advanced Research Projects Agency for Health (ARPA-H)'s Sprint for Women’s Health, San Diego County Air Pollution Control District considers source rule on warehouse delivery vehicles, and more. Read the full edition here: https://bit.ly/48oyTGx

It’s #NewMemberMonday!   🔬MannKind Corporation creates products for people living with endocrine and orphan lung diseases ✨ #MeijiSeikaPharma is improving the quality of care and lowering drugs costs for patients worldwide 👩🔬 TGen - Part of City of Hope is translating genomic research into life-changing results 💰 TPG is a global alternative asset firm investing in growth, change and innovation 

In this month’s Biocom California Newsletter, learn about BioLabs' Golden Ticket Competition for startups, Medrio’s new report on securing biopharma funding, Gov. Newsom vetoes AI safety bill and more. Read the full edition here: https://bit.ly/4eZXCUq

Dive into the world of data-driven insights in UC San Diego Extended Studies' Biostatistics in Healthcare online course. It offers real-word applications for professionals in health sciences, medical research, public health and more. Learn more here: https://bit.ly/40gydBk

With 1,800 companies in our community, representing $1B in buying power, Biocom California members saved $376M last year on their lab supplies, HR benefits, travel costs and more. Explore our portfolio of programs: https://bit.ly/4dzDLdD

Passionate about fostering diversity in life sciences? Help veterans and underrepresented job seekers navigate their careers while enhancing your leadership skills and expanding your professional network. Apply now: https://bit.ly/3BY9LKT #Mentorship

In the October edition of LifeLines, we highlighted member companies driving the latest advancements in AI and drug discovery, including BigHat Biosciences, Genesis Therapeutics, insitro and more. Read the story here: https://bit.ly/40y9yIH

Congratulations to our member Cryoport Systems on their new strategic collaboration with SK pharmteco to support its manufacture of APIs and intermediates, biopharmaceuticals and cell and gene therapies. Read more here: https://bit.ly/48ogARZ